subject: CHEBI:7454

object_name: Respiratory insufficiency


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: dental caries

tested_intervention: yes


subject: UMLS:C2346514

object_name: Dental Caries, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: myxoid liposarcoma

tested_intervention: unsure


subject: CHEBI:41879

object_name: myxoid/round cell liposarcoma


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UMLS:C5555460

subject_name: Recombinant human alkaline phosphatase

object_name: Acute kidney injury due to sepsis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:91398

subject_name: Tivantinib


subject: CHEBI:91398

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4684978

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Nonulcer dyspepsia


subject: CHEBI:31355

subject_name: Carboplatin

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:31355

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:31355

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:31355

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:31355

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:31355

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:31355

object_name: human papilloma virus infection


subject: CHEBI:31355

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:31355

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:31355

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:31355

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:31355

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:31355

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:31355

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:31355

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C5666963

subject_name: Lyophilized Inactivated Group A Streptococcus TARA-002

object_name: superficial urinary bladder carcinoma


subject: MESH:C558471

subject_name: Hizentra

object_name: Secondary immune deficiency disorder


subject: CHEBI:64816

object_name: uterine sarcoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:5864

subject_name: Ifosfamide


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:137064

subject_name: Galunisertib

object_name: Estrogen Receptor Negative


subject: CHEBI:137064

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:137064

object_name: Carcinoma breast stage IV


subject: CHEBI:137064

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:137064

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:137064

object_name: Progesterone Receptor Negative


subject: CHEBI:137064

object_name: triple-negative breast carcinoma


subject: CHEBI:137064

object_name: HER2/Neu Negative


subject: CHEBI:137064

object_name: Breast cancer recurrent


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Gastric Mixed Adenocarcinoma


subject: CHEBI:31348

object_name: diffuse gastric adenocarcinoma


subject: CHEBI:31348

object_name: gastric intestinal type adenocarcinoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: recurrent gastric cancer


subject: CHEBI:177533

subject_name: Quarfloxin

object_name: B-cell chronic lymphocytic leukemia


subject: MESH:C545184


subject: CHEBI:8802

subject_name: Remifentanil

object_name: ventricular tachycardia


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: chronic kidney disease


subject: CHEBI:3654

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: kidney disorder


subject: CHEBI:61033

subject_name: Fondaparinux


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Stomach cancer


subject: UNII:B2K5L1L8S9

object_name: gastric cancer


subject: CHEBI:50693

subject_name: Milrinone

object_name: Cerebral Vasospasm


subject: CHEBI:135983

subject_name: Teriparatide

object_name: spinal fracture


subject: CHEBI:135983

object_name: Spinal Fracture, CTCAE


subject: CHEBI:135983

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:135983

object_name: Back pain


subject: CHEBI:135983

object_name: Back Pain, CTCAE 3.0


subject: UNII:0DXG50I4WD

object_name: Childhood Solid Neoplasm


subject: UNII:0DXG50I4WD

object_name: Adult Solid Neoplasm


subject: UNII:0DXG50I4WD

object_name: Solid Neoplasm


subject: UMLS:C3827099


subject: UMLS:C3827099


subject: UMLS:C3827099


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: UMLS:C0534628

subject_name: Endostatins

object_name: lung cancer


subject: UMLS:C0534628

object_name: lung neoplasm


subject: UMLS:C0534628

object_name: lung carcinoma


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: UMLS:C5555042

subject_name: Danvilostomig

object_name: non-small cell lung carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Stage II Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Stage I Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: CD20 Positive


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: Diffuse large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Metastatic Cutaneous Melanoma


subject: UNII:16VY3TM7ZO

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:16VY3TM7ZO

object_name: metastatic melanoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C5239569

subject_name: PhosphoLean

object_name: Weight loss


subject: UMLS:C5239569

object_name: Weight Loss, CTCAE


subject: PUBCHEM.COMPOUND:134461434

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IIA Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174

object_name: colon adenocarcinoma


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Sydenham chorea


subject: UNII:WD5DUG7X38

object_name: chronic hepatitis C virus infection


subject: UNII:4A2Y23XK11

subject_name: Lazertinib

object_name: Metastatic non-small cell lung cancer


subject: UNII:1IJV77EI07

subject_name: Tepotinib


subject: CHEBI:7726

subject_name: octreotide

object_name: Constipation


subject: CHEBI:7726

object_name: Constipation, CTCAE


subject: CHEBI:231621

subject_name: Tasisulam

object_name: Advanced cancer


subject: CHEBI:8774

subject_name: Ramipril

object_name: glomerulonephritis


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Hyponatremia


subject: UMLS:C0445115

object_name: Hyponatremia, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Anal chlamydia infection


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C1440044

subject_name: A,B

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1440044

object_name: Embolism, Tumor


subject: UMLS:C1440044

object_name: Neoplasm Metastasis


subject: UNII:3W1JG795YI

subject_name: SUNFLOWER OIL

object_name: Inflammation


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: UNII:5730VNW22X

object_name: osteoporosis


subject: UNII:5730VNW22X

object_name: Encounter due to family history of osteoporosis


subject: UNII:5730VNW22X

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:5730VNW22X

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: opioid use


subject: UMLS:C0359953

object_name: Post-Operative Pain


subject: UMLS:C0359953

object_name: Pelvic prolapse


subject: CHEMBL.COMPOUND:CHEMBL2108506

subject_name: INTERFERON ALFA

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL2108506

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108506


subject: CHEMBL.COMPOUND:CHEMBL2108506

object_name: viral respiratory tract infection


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UMLS:C0043112

subject_name: WELL-FERON


subject: UMLS:C0043112


subject: UMLS:C0043112


subject: UMLS:C0043112


subject: UMLS:C0751598

subject_name: Alferon


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UMLS:C2825023


subject: UMLS:C2825023


subject: GTOPDB:8935

subject_name: lenzilumab


subject: GTOPDB:8935


subject: GTOPDB:8935


subject: CHEMBL.COMPOUND:CHEMBL3707325

subject_name: LENZILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707325


subject: CHEMBL.COMPOUND:CHEMBL3707325


subject: UMLS:C4087043


subject: UMLS:C4087043


subject: UMLS:C4087043


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:188074

object_name: cardiovascular disorder


subject: CHEBI:188074

object_name: chronic disease


subject: CHEBI:188074

object_name: Chronic Disease


subject: CHEBI:188074

object_name: kidney disorder


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: nonpapillary renal cell carcinoma


subject: UNII:B72HH48FLU

object_name: clear cell renal carcinoma


subject: UNII:B72HH48FLU

object_name: renal cell adenocarcinoma


subject: UNII:B72HH48FLU

object_name: renal cell carcinoma


subject: UNII:B72HH48FLU

object_name: melanoma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:7514

subject_name: Neostigmine

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEMBL.COMPOUND:CHEMBL4802266

subject_name: REBONUPUTEMCEL

object_name: intervertebral disk degenerative disorder


subject: CHEMBL.COMPOUND:CHEMBL4802266

object_name: lumbar disk degenerative disorder


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Acute migraine


subject: PR:000001786

object_name: colorectal cancer


subject: PR:000001786

object_name: colorectal carcinoma


subject: PR:000001786

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: psychosis


subject: CHEBI:567361

subject_name: Cladribine

object_name: Langerhans cell histiocytosis


subject: CHEBI:567361

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:567361

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Relapse multiple myeloma


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: primary biliary cholangitis 1


subject: CHEBI:83766

subject_name: Olaparib

object_name: cervical cancer


subject: CHEBI:83766

object_name: cervical carcinoma


subject: UMLS:C0962969

subject_name: RAD 001

object_name: malignant soft tissue neoplasm


subject: UMLS:C0962969

object_name: sarcoma


subject: UMLS:C0962969

object_name: Childhood Solid Neoplasm


subject: UMLS:C0962969

object_name: Adult Solid Neoplasm


subject: UMLS:C0962969

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:5391

subject_name: Glucagon

object_name: Fasting hypoglycemia


subject: CHEBI:139072

object_name: fragile X syndrome


subject: CHEBI:139072

object_name: Cognitive impairment


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: PUBCHEM.COMPOUND:70789204

object_name: skin squamous cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:6801

subject_name: Metformin

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:6801

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:6801

object_name: Lymphocytosis


subject: CHEBI:6801

object_name: Plasma cell myeloma refractory


subject: CHEBI:6801

object_name: Plasma cell myeloma recurrent


subject: CHEBI:6801

object_name: Lymphadenopathy


subject: CHEBI:6801

object_name: thrombocytopenia


subject: CHEBI:6801

object_name: anemia


subject: CHEBI:6801

object_name: Anemia, CTCAE


subject: CHEBI:6801

object_name: Night sweats


subject: CHEBI:6801

object_name: Splenomegaly


subject: CHEBI:6801

object_name: Weight loss


subject: CHEBI:6801

object_name: Weight Loss, CTCAE


subject: CHEBI:6801

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:6801

object_name: Fatigue


subject: CHEBI:6801

object_name: Fever


subject: CHEBI:6801

object_name: Fever symptoms (finding)


subject: CHEBI:6801

object_name: Fever, CTCAE


subject: CHEBI:45409

subject_name: Ritonavir

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:45409

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:45409

object_name: Lymphocytosis


subject: CHEBI:45409

object_name: Plasma cell myeloma refractory


subject: CHEBI:45409

object_name: Plasma cell myeloma recurrent


subject: CHEBI:45409

object_name: Lymphadenopathy


subject: CHEBI:45409

object_name: thrombocytopenia


subject: CHEBI:45409

object_name: anemia


subject: CHEBI:45409

object_name: Anemia, CTCAE


subject: CHEBI:45409

object_name: Night sweats


subject: CHEBI:45409

object_name: Splenomegaly


subject: CHEBI:45409

object_name: Weight loss


subject: CHEBI:45409

object_name: Weight Loss, CTCAE


subject: CHEBI:45409

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:45409

object_name: Fatigue


subject: CHEBI:45409

object_name: Fever


subject: CHEBI:45409

object_name: Fever symptoms (finding)


subject: CHEBI:45409

object_name: Fever, CTCAE


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: pneumonia


subject: RXCUI:901639

object_name: COVID-19-Associated Pneumonia


subject: RXCUI:901639

object_name: bacteriemia


subject: RXCUI:901639

object_name: meningitis


subject: RXCUI:901639

object_name: Meningitis, CTCAE


subject: RXCUI:901639

object_name: Sepsis


subject: RXCUI:901639

object_name: Sepsis, CTCAE


subject: UMLS:C3252923

subject_name: synflorix


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: CHEBI:18220

subject_name: Isoflavone

object_name: Hot Flashes, CTCAE


subject: CHEBI:18220

object_name: Hot flashes


subject: UMLS:C0074926

subject_name: Soy Proteins


subject: UMLS:C0074926


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Primary malignant neoplasm


subject: CHEBI:31355

object_name: childhood malignant neoplasm


subject: CHEBI:31355

object_name: Malignant obstetric neoplasm


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Solid Neoplasm


subject: CHEBI:3638


subject: CHEBI:3638

object_name: cancer


subject: CHEBI:3638


subject: CHEBI:3638


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Albuminuria


subject: UNII:S7H48S6K7H

subject_name: Troriluzole

object_name: Compulsion


subject: CHEBI:6121

subject_name: Ketamine

object_name: brain ischemia


subject: UMLS:C0013162

subject_name: Drug Combinations


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Pertrochanteric fracture


subject: CHEBI:4466

object_name: Postoperative Pain, Acute


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: HIV infection


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: CHEBI:17439


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: UMLS:C0178638

subject_name: folate


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: end stage renal failure


subject: UMLS:C3714501

object_name: Chronic uremia


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Small cell lung cancer extensive stage


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: male breast carcinoma


subject: UNII:YZS3R7LP44

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: malignant neoplasm of breast stage I


subject: UNII:YZS3R7LP44

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Carcinoma breast stage I


subject: UNII:YZS3R7LP44

object_name: Breast cancer stage II


subject: UNII:YZS3R7LP44

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:YZS3R7LP44

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:YZS3R7LP44

object_name: Stage IIIA Breast Carcinoma


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: circadian rhythm sleep disorder, shift work type


subject: UNII:939U7C91AI

object_name: Shift work disorder


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod

object_name: Recurrent ovarian cancer


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UMLS:C3181507

object_name: agammaglobulinemia


subject: UMLS:C3181507

object_name: syndromic agammaglobulinemia


subject: UMLS:C3181507

object_name: plasma cell myeloma


subject: UMLS:C3181507

object_name: Acquired Hypogammaglobulinemia


subject: PUBCHEM.COMPOUND:135125140

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:135125140

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:135125140

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135125140

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135125140

object_name: acute myeloid leukemia


subject: UMLS:C5446606

subject_name: Crelosidenib


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: CHEBI:10125

subject_name: Zolpidem

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:10125


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:31186

object_name: Oral Mucositis


subject: CHEBI:31186

object_name: stomatitis


subject: CHEBI:31186

object_name: oral mucositis


subject: UNII:6V9JH46E20

subject_name: SITAXENTAN SODIUM

object_name: pulmonary hypertension, primary, 1


subject: UNII:6V9JH46E20

object_name: pulmonary hypertension


subject: UNII:6V9JH46E20

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:6V9JH46E20

object_name: pulmonary arterial hypertension


subject: UMLS:C1952549

subject_name: Sitaxentan sodium


subject: UMLS:C1952549


subject: UMLS:C1952549


subject: CHEBI:18132

subject_name: phosphocholine

object_name: B-cell neoplasm


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: CHEBI:174615

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:681569

subject_name: Clofarabine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:82339

subject_name: Merphalan


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:9570

subject_name: Thiotepa


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: sickle cell disease


subject: CHEBI:8892

object_name: malignant soft tissue neoplasm


subject: CHEBI:8892

object_name: sarcoma


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: GTOPDB:13403

subject_name: marstacimab

object_name: hemophilia B


subject: GTOPDB:13403

object_name: hemophilia B leyden


subject: GTOPDB:13403

object_name: hemophilia A


subject: UNII:0UB3OA67O7


subject: UNII:0UB3OA67O7


subject: UNII:0UB3OA67O7


subject: UMLS:C5226892


subject: UMLS:C5226892


subject: UMLS:C5226892


subject: CHEBI:8988

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:8988

object_name: Esophageal adenocarcinoma stage IV


subject: CHEBI:8988

object_name: Advanced Gastric Adenocarcinoma


subject: CHEBI:8988

object_name: Advanced Esophageal Adenocarcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: GTOPDB:13396

subject_name: ivonescimab


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: GTOPDB:13396


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Clonal Cytopenia of Undetermined Significance


subject: PR:000010535

subject_name: kinesin-like protein KIF20B

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: cervix; insufficient dilatation in labor


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Menopause present (finding)


subject: CHEBI:135285

object_name: Menopause


subject: CHEBI:135285

object_name: Osteopenia


subject: CHEBI:135285

object_name: osteoporosis


subject: CHEBI:135285

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:135285

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:135285

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4727248

subject_name: DBPR 112

object_name: Neck Carcinoma


subject: UMLS:C4727248

object_name: head and neck neoplasm


subject: UMLS:C4727248

object_name: head and neck cancer


subject: UMLS:C4727248

object_name: non-small cell lung carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: peritoneal mesothelioma


subject: CHEBI:4026

object_name: malignant peritoneal mesothelioma


subject: CHEBI:4026

object_name: ovarian adenocarcinoma


subject: CHEBI:4026

object_name: fallopian tube adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Breast neoplasm female


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: noise induced hearing loss


subject: CHEBI:6888

object_name: acoustic trauma (history)


subject: CHEBI:10127

subject_name: Zonisamide


subject: CHEBI:75417

subject_name: dibenzoylmethane

object_name: Orofacial cleft


subject: CHEBI:34853

subject_name: Mitobronitol


subject: CHEBI:60815

subject_name: lysobisphosphatidic acid


subject: UMLS:C0053932

subject_name: Bone Morphogenetic Proteins


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: Barotrauma


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: Advanced Urothelial Carcinoma


subject: UNII:BMO5G62HGB

subject_name: FLORBETABEN

object_name: Alzheimer disease type 1


subject: UNII:BMO5G62HGB

object_name: Alzheimer disease


subject: UMLS:C2352589


subject: UMLS:C2352589


subject: CHEMBL.COMPOUND:CHEMBL2109084

subject_name: DESMOTEPLASE

object_name: Acute Ischemic Stroke


subject: CHEMBL.COMPOUND:CHEMBL2109084

object_name: Ischemic stroke


subject: UMLS:C0141449

subject_name: Desmoteplase


subject: UMLS:C0141449


subject: CHEBI:27732

subject_name: Caffeine

object_name: cancer


subject: CHEBI:27732

object_name: neoplasm


subject: CHEBI:37845

subject_name: growth hormone

object_name: Mild Traumatic Brain Injury


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: PUBCHEM.COMPOUND:56603532

subject_name: Pracinostat

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:56603532

object_name: acute myeloid leukemia


subject: UMLS:C1883555

subject_name: Whey Protein Isolate

object_name: Appetite and general nutritional disorders


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: periodontitis, chronic, adult


subject: CHEBI:39548

object_name: chronic periodontitis


subject: CHEBI:75722

subject_name: Tramadol

object_name: Opioid-Induced Bowel Dysfunction


subject: UMLS:C4505937

object_name: migraine


subject: UMLS:C4505937

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C0376196

subject_name: Opiates

object_name: Inguinal hernia


subject: MESH:D053610

subject_name: Opiate Alkaloids


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C5959635

subject_name: KRAS G12C Inhibitor FMC-376

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5959635


subject: UMLS:C5959635

object_name: Unresectable Solid Neoplasm


subject: UMLS:C5959635

object_name: Adult Solid Neoplasm


subject: UMLS:C5959635

object_name: pancreatic neoplasm


subject: UMLS:C5959635

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5959635

object_name: malignant pancreatic neoplasm


subject: UMLS:C5959635

object_name: non-small cell lung carcinoma


subject: UMLS:C5959635

object_name: colorectal cancer


subject: UMLS:C5959635

object_name: colorectal carcinoma


subject: UMLS:C5959635

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:T4H02O147G

subject_name: simmitecan

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:34Q82842ZK

subject_name: SIMMITECAN


subject: CHEBI:74947

subject_name: Thalidomide


subject: UNII:P89DR4NY54

object_name: hemophilia A


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Impulsive aggression


subject: CHEBI:8107

object_name: post-traumatic stress disorder


subject: CHEBI:132922

object_name: severe acute respiratory syndrome


subject: CHEBI:132922

object_name: congenital alveolar dysplasia


subject: CHEBI:132922

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:132922

object_name: newborn respiratory distress syndrome


subject: CHEBI:132922

object_name: Coronavinae infectious disease


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid

object_name: peripheral vascular disease


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Chuvash polycythemia


subject: UNII:564AW1RR37

subject_name: zegocractin

object_name: acute pancreatitis


subject: DRUGBANK:DB16466


subject: UMLS:C0561929

subject_name: N-3 fatty acid supplementation

object_name: Old myocardial infarction


subject: CHEBI:53218

object_name: COPD, severe early onset


subject: CHEBI:53218

object_name: chronic obstructive pulmonary disease


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: Jervell and Lange-Nielsen syndrome


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: atrial fibrillation


subject: CHEBI:41879

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:41879

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:231683

subject_name: Anakinra

object_name: multiple sclerosis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: cardiovascular disorder


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904

object_name: hyperlipidemia


subject: CHEBI:6904

object_name: hyperlipoproteinemia


subject: CHEBI:6904

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:6904

object_name: Serum lipids high (finding)


subject: CHEBI:28787

subject_name: Nitroglycerin


subject: CHEBI:28787


subject: CHEBI:28787


subject: CHEBI:28787


subject: CHEBI:28787


subject: UMLS:C0729203

subject_name: Omnipaque


subject: UMLS:C0729203


subject: UMLS:C0729203


subject: UMLS:C0729203


subject: UMLS:C0729203


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: UMLS:C0061366

subject_name: Glucantime

object_name: cutaneous leishmaniasis


subject: GTOPDB:7730

subject_name: bococizumab


subject: CHEMBL.COMPOUND:CHEMBL3137349

subject_name: BOCOCIZUMAB


subject: UMLS:C4043705


subject: UMLS:C5227743


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Neonatal infection


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3534


subject: CHEBI:59594

subject_name: Colesevelam

object_name: glucose metabolism disease


subject: CHEBI:59594

object_name: hypercholanemia, familial 1


subject: CHEBI:59594

object_name: bariatric surgery candidate


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: ovary leiomyosarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: GTOPDB:13787

subject_name: ongericimab

object_name: Familial hypercholesterolemia - heterozygous


subject: UNII:X126G5DZ36

subject_name: ONGERICIMAB


subject: UMLS:C5421036

subject_name: Ongericimab


subject: PUBCHEM.COMPOUND:155166738

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:155166738

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:155166738

object_name: chronic obstructive pulmonary disease


subject: CHEBI:27470

subject_name: Folic acid

object_name: Adverse reaction to arsenic and/or arsenic compound


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: neuropathy, small fiber


subject: UMLS:C0085297

object_name: primary erythermalgia


subject: UMLS:C0085297

object_name: Idiopathic peripheral neuropathy


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: Childhood Breast Carcinoma


subject: UMLS:C2608320

object_name: breast carcinoma


subject: UMLS:C2608320

object_name: breast cancer


subject: CHEBI:63632

subject_name: Topotecan

object_name: adult lymphoma


subject: CHEBI:63632

object_name: lymphoma


subject: CHEBI:63632

object_name: carcinoma of esophagus


subject: CHEBI:63632

object_name: esophageal cancer


subject: CHEBI:63632

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:63632

object_name: neoplasm of esophagus


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: follicular lymphoma


subject: UMLS:C2826153

object_name: Childhood Solid Neoplasm


subject: UMLS:C2826153

object_name: Adult Solid Neoplasm


subject: UMLS:C2826153

object_name: Solid Neoplasm


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: kidney failure


subject: UMLS:C5555576

subject_name: Muzastotug


subject: UMLS:C5555576


subject: UMLS:C5555576


subject: UMLS:C5785442


subject: UMLS:C5785442


subject: UMLS:C5785442


subject: CHEBI:132767

subject_name: Ferric pyrophosphate

object_name: chronic kidney disease


subject: CHEBI:132767

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:132767

object_name: anemia


subject: CHEBI:132767

object_name: Anemia, CTCAE


subject: UMLS:C1449662

subject_name: Levulan

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Colorectal cancer recurrent


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C0718116

subject_name: vitamin A and D topical

object_name: acne


subject: CHEBI:35155

subject_name: elemental calcium

object_name: Androgen excess


subject: CHEBI:35155

object_name: vitamin D deficiency


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:9150

subject_name: Simvastatin

object_name: optic neuritis


subject: UNII:5YSY733NA3


subject: UMLS:C2987373


subject: CHEBI:31824

subject_name: Mesna

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:31824

object_name: obesity


subject: CHEBI:31824

object_name: Obesity, CTCAE


subject: CHEBI:31824

object_name: Drug action (disorder)


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: MESH:C000716647

object_name: Chronic cough


subject: UNII:4W6JDK2PLY

subject_name: Olumacostat glasaretil


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Oral Complication of Radiation Therapy


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Radiation Sickness


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: type 1 diabetes mellitus 1


subject: UNII:73SM5SF3OR

object_name: type 1 diabetes mellitus


subject: CHEBI:229233

subject_name: Ritlecitinib


subject: CHEBI:229233


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: adult lymphoma


subject: CHEBI:47519

object_name: lymphoma


subject: CHEBI:47519

object_name: pediatric lymphoma


subject: UNII:6897GXD6OE

object_name: cancer


subject: UNII:6897GXD6OE

object_name: neoplasm


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution


subject: UMLS:C2984024


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:9907

subject_name: ursodiol

object_name: Class 3 Obesity


subject: PUBCHEM.COMPOUND:66586232

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:66586232

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:66586232

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:66586232

object_name: Postoperative Complications


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: UMLS:C5447471

subject_name: CXCR2 Agonist MGTA-145

object_name: plasma cell myeloma


subject: CHEBI:8212

subject_name: Pimozide

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:8212

object_name: amyotrophic lateral sclerosis


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Stress


subject: CHEBI:42567

subject_name: Fisetin

object_name: chronic kidney disease


subject: CHEBI:42567

object_name: diabetic kidney disease


subject: CHEBI:42567

object_name: diabetes mellitus


subject: CHEBI:151315

subject_name: Heparin

object_name: Pulmonary Embolism Related to COVID-19


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C0003921

subject_name: artificial tears (medication)

object_name: xerophthalmia


subject: UMLS:C0003921

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops


subject: UMLS:C2608262


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Addictive amphetamine use


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:64312

subject_name: Memantine


subject: UMLS:C5435405

object_name: Sicca Syndrome


subject: UMLS:C1704263

subject_name: green tea extract

object_name: colon carcinoma


subject: UMLS:C1704263

object_name: colorectal cancer


subject: UMLS:C1704263

object_name: colon cancer


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: CHEBI:49134

object_name: malignant soft tissue neoplasm


subject: CHEBI:49134

object_name: sarcoma


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: UMLS:C5700219


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Primary malignant neoplasm


subject: UNII:SSB9S6N20R

object_name: postherpetic neuralgia


subject: CHEBI:7476

subject_name: Naproxen

object_name: Symptomatic irreversible pulpitis


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: Advanced Lymphoma


subject: UMLS:C4287690

object_name: Refractory Lymphoma


subject: UMLS:C4287690

object_name: B-cell lymphoma refractory


subject: UMLS:C4287690

object_name: T-cell lymphoma refractory


subject: UMLS:C4287690

object_name: Refractory Pancreatic Carcinoma


subject: UMLS:C4287690

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4287690

object_name: B-cell neoplasm


subject: UMLS:C4287690

object_name: Advanced Pancreatic Carcinoma


subject: UMLS:C4287690

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C4287690

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C4287690

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C4287690

object_name: stage IV pancreatic cancer


subject: UMLS:C4287690

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEMBL.COMPOUND:CHEMBL5095231

subject_name: TULMIMETOSTAT

object_name: Castration-Sensitive Prostate Carcinoma


subject: UNII:OUQ4N85Z0B


subject: MESH:D003069

subject_name: Coffee

object_name: Postoperative ileus


subject: CHEBI:31355

subject_name: Carboplatin

object_name: malignant exocrine pancreas neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:T41737F88A

subject_name: Tisotumab vedotin


subject: UNII:T41737F88A

object_name: head and neck squamous cell carcinoma


subject: UNII:T41737F88A

object_name: non-small cell lung carcinoma


subject: UNII:T41737F88A

object_name: colorectal neoplasm


subject: UMLS:C3827178

subject_name: HuMax-TF-ADC


subject: UMLS:C3827178


subject: UMLS:C3827178


subject: UMLS:C3827178


subject: UMLS:C5907938

subject_name: Anti-nectin-4 Antibody-drug Conjugate ADRX-0706

object_name: Solid Neoplasm


subject: UMLS:C5907938

object_name: cervical cancer


subject: UMLS:C5907938

object_name: cervical carcinoma


subject: CHEBI:3380

subject_name: Captopril

object_name: myelofibrosis


subject: CHEBI:3380

object_name: Bone Marrow Fibrosis


subject: CHEBI:3380

object_name: myeloproliferative neoplasm


subject: CHEBI:3380

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: MESH:C112669

subject_name: gadolinium DOTA meglumine

object_name: heart failure


subject: MESH:C112669

object_name: Heart Failure, CTCAE


subject: MESH:C112669

object_name: Left ventricular hypertrophy


subject: MESH:C112669

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: MESH:C112669

object_name: myocardial infarction


subject: MESH:C112669

object_name: Myocardial Infarction, CTCAE


subject: MESH:C112669

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:35176

object_name: obesity


subject: CHEBI:35176

object_name: Obesity, CTCAE


subject: UMLS:C2985197

object_name: prostate carcinoma


subject: UMLS:C2985197

object_name: prostate cancer


subject: UMLS:C2985197

object_name: cancer


subject: UMLS:C2985197

object_name: neoplasm


subject: UMLS:C2985197

object_name: adult lymphoma


subject: UMLS:C2985197

object_name: lymphoma


subject: UMLS:C2985197

object_name: pediatric lymphoma


subject: UMLS:C2985197

object_name: melanoma


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Insulin Sensitivity


subject: CHEBI:2719

subject_name: Angiotensin II


subject: PR:000036009

subject_name: angiotensin II


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: CHEBI:31355

object_name: Stage II Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:QY8BWX1LJ5

subject_name: Taladegib


subject: UNII:QY8BWX1LJ5

object_name: Stage IB Esophageal Adenocarcinoma AJCC v7


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5

object_name: Stage IIA Esophageal Adenocarcinoma AJCC v7


subject: UNII:QY8BWX1LJ5

object_name: Stage IIB Esophageal Adenocarcinoma AJCC v7


subject: UNII:QY8BWX1LJ5

object_name: Stage IIIA Esophageal Adenocarcinoma AJCC v7


subject: UNII:QY8BWX1LJ5

object_name: Stage IIIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31824

subject_name: Mesna

object_name: renal carcinoma


subject: CHEBI:31824

object_name: kidney neoplasm


subject: CHEBI:31824

object_name: kidney cancer


subject: CHEBI:31824

object_name: liver cancer


subject: CHEBI:31824

object_name: liver neoplasm


subject: CHEBI:31824

object_name: Adult Liver Carcinoma


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: retinoblastoma


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: AL amyloidosis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C2349988

subject_name: Myobacterium w (attenuated)

object_name: optic neuritis


subject: CHEBI:74709

subject_name: Met-Trp


subject: UMLS:C5854369

subject_name: Site Specific Immunomodulator QBECO

object_name: ulcerative colitis


subject: CHEBI:2453

subject_name: Acyclovir

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:3561

subject_name: Cetirizine


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: CHEBI:8776

subject_name: ranitidine


subject: UMLS:C2345444

subject_name: Clinisol 15

object_name: type 2 diabetes mellitus


subject: UMLS:C2345444

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2345444

object_name: obesity


subject: UMLS:C2345444

object_name: Obesity, CTCAE


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17634


subject: CHEBI:17634


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Critical Illness


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:129896932

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:129896932

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:129896932

object_name: breast cancer


subject: PUBCHEM.COMPOUND:129896932

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:129896932

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:129896932

object_name: malignant neoplasm of breast stage IV


subject: PUBCHEM.COMPOUND:129896932

object_name: breast neoplasm


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UNII:RRY5XN588Q


subject: UMLS:C5907970

subject_name: Rac/Cdc42 Inhibitor MBQ-167


subject: UMLS:C5907970


subject: UMLS:C5907970


subject: UMLS:C5907970


subject: UMLS:C5907970


subject: UMLS:C5907970


subject: UMLS:C5907970


subject: CHEBI:31824

subject_name: Mesna

object_name: adult medulloblastoma


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:143658


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: laryngostenosis


subject: PUBCHEM.COMPOUND:5281767

object_name: Laryngeal Stenosis, CTCAE


subject: PUBCHEM.COMPOUND:5281767

object_name: Congenital glottic web of larynx


subject: PUBCHEM.COMPOUND:5281767

object_name: laryngeal papillomatosis


subject: PUBCHEM.COMPOUND:5281767

object_name: larynx squamous papilloma


subject: PUBCHEM.COMPOUND:5281767

object_name: Leukoplakia of larynx


subject: PUBCHEM.COMPOUND:5281767

object_name: Polyp of larynx


subject: PUBCHEM.COMPOUND:5281767

object_name: glottis carcinoma


subject: CHEBI:167574

subject_name: Semaglutide

object_name: osteoporosis


subject: CHEBI:167574

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:167574

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:167574

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:167574

object_name: Osteoporotic Fractures


subject: CHEBI:27605

subject_name: Psicose

object_name: Finding of blood glucose level


subject: UMLS:C5445196

subject_name: Oxaliplatin Liquid Injection

object_name: Stomach cancer


subject: UMLS:C5445196

object_name: gastric cancer


subject: CHEBI:132774

subject_name: Roxadustat

object_name: Anemia in chronic kidney disease


subject: UMLS:C3713379


subject: CHEBI:8364

subject_name: Prazosin

object_name: Cannabis use disorder


subject: CHEBI:8364

object_name: cannabis abuse


subject: CHEBI:3745

subject_name: clindamycin

object_name: bacteriemia


subject: CHEBI:3745

object_name: Bacteremia, CTCAE


subject: CHEBI:3745

object_name: endocarditis


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:62880

subject_name: Veliparib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:62880

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:62880

object_name: Prostate cancer recurrent


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: biologic; inadequate


subject: UMLS:C3642349

subject_name: Volulyte

object_name: Severe Sepsis


subject: UMLS:C0879399

subject_name: tositumomab

object_name: relapsing-remitting multiple sclerosis


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Melanoma in situ


subject: UNII:M89N0Q7EQR

object_name: Stage 0 Cutaneous Melanoma AJCC v6 and v7


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:41423

subject_name: Celecoxib

object_name: tuberculosis


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Pain in female genitalia on intercourse


subject: PUBCHEM.COMPOUND:134506

object_name: Dyspareunia


subject: PUBCHEM.COMPOUND:134506

object_name: Dyspareunia, CTCAE


subject: PUBCHEM.COMPOUND:134506

object_name: Painful intercourse female


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:7421

subject_name: NAC

object_name: thrombotic microangiopathy


subject: CHEBI:31159

subject_name: Aceclofenac

object_name: Medication interaction potentiation


subject: CHEBI:135544

subject_name: Ilaprazole


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Recurrence


subject: UMLS:C0919079

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C0919079

object_name: Recurrent disease


subject: UMLS:C0919079

object_name: Recurrent tumor


subject: UMLS:C0919079

object_name: Disease Progression


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: endogenous depression


subject: UMLS:C3714501

object_name: major depressive disorder


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: Hemorrhagic Shock


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: HIV infection


subject: PUBCHEM.COMPOUND:6093202

subject_name: Nicotinamide Mononucleotide


subject: CHEBI:14648

subject_name: NMN(+)


subject: CHEBI:16664

subject_name: Albendazole

object_name: Anemia, CTCAE


subject: CHEBI:16664

object_name: Cardiovascular surgery result: exercise tolerance


subject: UMLS:C3896807

object_name: Relapse multiple myeloma


subject: UMLS:C3896807

object_name: Plasma cell myeloma recurrent


subject: CHEBI:27560

subject_name: Boron


subject: CHEBI:27560


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:61080

subject_name: Romidepsin

object_name: bladder tumor


subject: CHEBI:61080

object_name: urinary bladder carcinoma


subject: CHEBI:61080

object_name: urinary bladder cancer


subject: CHEBI:61080

object_name: childhood bladder carcinoma


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:55312

subject_name: diphenylmethane monoisocyanate

object_name: Graves disease


subject: MESH:D064112

subject_name: Clustered Regularly Interspaced Short Palindromic Repeats

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: UMLS:C4277678

subject_name: Transcription Activator-Like Effector Nucleases


subject: UNII:RU921DS4Z5

object_name: Renal anaemia


subject: DRUGBANK:DB16596

subject_name: Apple cider vinegar

object_name: Prediabetes


subject: GTOPDB:2479

subject_name: HCl


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Back Pain, CTCAE 5.0


subject: UMLS:C0678449

object_name: Back pain


subject: UMLS:C0678449

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C0678449

object_name: Neck pain


subject: UMLS:C0678449

object_name: Neck Pain, CTCAE 5.0


subject: UMLS:C0678449

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C3272413

subject_name: STAT3 Inhibitor OPB-51602

object_name: Advanced cancer


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Hypertension stage 1


subject: GTOPDB:4890

subject_name: brain natriuretic peptide


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Surviving free of recurrence of neoplastic disease


subject: CHEBI:151315

subject_name: Heparin

object_name: prostate carcinoma


subject: CHEBI:151315

object_name: prostate cancer


subject: CHEBI:151315

object_name: lung cancer


subject: CHEBI:151315

object_name: lung neoplasm


subject: CHEBI:151315

object_name: lung carcinoma


subject: CHEBI:151315

object_name: Childhood Breast Carcinoma


subject: CHEBI:151315

object_name: breast carcinoma


subject: CHEBI:151315

object_name: breast cancer


subject: CHEBI:151315

object_name: hepatic veno-occlusive disease


subject: CHEBI:151315

object_name: Venous occlusion


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803

object_name: colorectal cancer


subject: GTOPDB:6803

object_name: colorectal carcinoma


subject: GTOPDB:6803

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Gait


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:16899

subject_name: Mannitol

object_name: osteoarthritis, knee


subject: CHEBI:16899


subject: CHEBI:17924

subject_name: Sorbitol


subject: CHEBI:17924


subject: UMLS:C5433059

subject_name: seal oil

object_name: Chronic low back pain


subject: UMLS:C0717478

subject_name: BELLADONNA/OPIUM

object_name: Consent Type - Hysterectomy


subject: UMLS:C0717478

object_name: Post-Operative Pain


subject: UMLS:C4722471

object_name: non-small cell lung carcinoma


subject: UMLS:C5556844

subject_name: Anti-TMEFF2/Anti-CD3 Bispecific Antibody JNJ-70218902

object_name: neoplasm


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Immune-mediated colitis


subject: UNII:9RV78Q2002

subject_name: Vedolizumab


subject: UMLS:C1098513


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Breast neoplasm female


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


subject: CHEBI:27732

subject_name: Caffeine


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: kidney failure


subject: CHEBI:144421

subject_name: ferric citrate


subject: UMLS:C3828882

subject_name: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

object_name: Cytomegalovirus Positive


subject: UMLS:C3828882

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C3828882

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C3828882


subject: CHEBI:68595

subject_name: Telaprevir

object_name: kidney disorder


subject: UMLS:C0770151

subject_name: Sodium Chloride, Inhalation

object_name: asthma


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:10119

object_name: Psychotic Mood Disorders


subject: CHEBI:195181

subject_name: Alanylalanine

object_name: prostate neoplasm


subject: CHEBI:15843

subject_name: Arachidonate


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UNII:EM8Y79998C

subject_name: methyl malonate

object_name: Myocardial Reperfusion Injury


subject: UMLS:C4305964

object_name: rheumatoid arthritis


subject: UMLS:C2918039

subject_name: Natazia

object_name: Uses contraception (finding)


subject: DRUGBANK:DB15616

object_name: cerebral cavernous malformation


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: stage IB melanoma


subject: UNII:5TAA004E22

object_name: stage IIA melanoma


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:6704

subject_name: Mebendazole

object_name: Amebic colitis


subject: CHEBI:6704

object_name: amebiasis


subject: CHEBI:135493

subject_name: Quinfamide


subject: CHEBI:135493


subject: CHEBI:135493

object_name: helminthiasis


subject: PUBCHEM.COMPOUND:56843415

subject_name: miravirsen

object_name: hepatitis C


subject: UNII:Q083AJW7VS

subject_name: Miravirsen


subject: CHEBI:49140

object_name: cervical polyp


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Renal transplant rejection


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C2093603

subject_name: Rabbit


subject: RXCUI:596702

subject_name: Menactra

object_name: malaria


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Alzheimer disease type 1


subject: CHEBI:42797

object_name: Alzheimer disease


subject: UMLS:C0962969

subject_name: RAD 001

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UMLS:C2918046

subject_name: Venlafaxine Hydrochloride ER

object_name: Childhood Breast Carcinoma


subject: UMLS:C2918046

object_name: breast carcinoma


subject: UMLS:C2918046

object_name: breast cancer


subject: UMLS:C2918046

object_name: endogenous depression


subject: UMLS:C2918046

object_name: major depressive disorder


subject: CHEBI:16389

subject_name: Ubiquinone Q2


subject: PUBCHEM.COMPOUND:119058

subject_name: Ubiquinones


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Disorder caused by ureteric stent


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: transverse myelitis


subject: CHEBI:34385

object_name: myelitis


subject: CHEBI:34385

object_name: Idiopathic transverse myelitis


subject: CHEBI:34385

object_name: neuromyelitis optica


subject: CHEBI:8774

subject_name: Ramipril

object_name: Microalbuminuria due to type 2 diabetes mellitus


subject: CHEBI:8774

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Neck Carcinoma


subject: CHEBI:135931

object_name: head and neck neoplasm


subject: CHEBI:135931

object_name: head and neck cancer


subject: CHEBI:135931

object_name: oropharyngeal carcinoma


subject: CHEBI:135931

object_name: oropharynx cancer


subject: CHEBI:63631

subject_name: Topiramate

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Ventricular arrhythmias and cardiac arrest


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Postoperative cognitive dysfunction


subject: CHEBI:50368

subject_name: ChromaTech

object_name: type 1 diabetes mellitus 1


subject: CHEBI:50368

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:381525

subject_name: beta-L-Dioxolane-cytidine

object_name: leukemia


subject: PUBCHEM.COMPOUND:381525

object_name: childhood leukemia


subject: CHEBI:134886

subject_name: Troxacitabine


subject: CHEBI:134886


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: primary progressive multiple sclerosis


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: ovarian sarcoma


subject: CHEBI:64153

object_name: bone chondrosarcoma


subject: CHEBI:64153

object_name: chondrosarcoma


subject: CHEBI:64153

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:64153

object_name: Osteosarcoma recurrent


subject: CHEBI:64153

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: CHEBI:64153

object_name: AIDS-related primary central nervous system lymphoma


subject: CHEBI:64153

object_name: Recurrent tumors of the Ewing's family


subject: CHEBI:64153

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:64153

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:64153

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:64153

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:64153

object_name: Metastatic osteosarcoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:27732

subject_name: Caffeine

object_name: Postoperative ileus


subject: CHEBI:27732

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:27732

object_name: colorectal neoplasm


subject: CHEBI:27732

object_name: diverticulitis


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: type 2 diabetes mellitus


subject: UNII:TL60C27RLH

object_name: Diabetes


subject: UNII:TL60C27RLH

object_name: diabetes mellitus


subject: UNII:TL60C27RLH

object_name: hyperlipidemia


subject: UNII:TL60C27RLH

object_name: hyperlipoproteinemia


subject: UNII:TL60C27RLH

object_name: Hyperlipidemia, CTCAE


subject: UNII:TL60C27RLH

object_name: Serum lipids high (finding)


subject: UMLS:C5205491

subject_name: Anti-CD137 Agonistic Monoclonal Antibody ADG106

object_name: Childhood Solid Neoplasm


subject: UMLS:C5205491

object_name: Adult Solid Neoplasm


subject: UMLS:C5205491

object_name: Solid Neoplasm


subject: UMLS:C5205491

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5205491

object_name: non-Hodgkin lymphoma


subject: UMLS:C5205491

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5205491

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: adult hepatocellular carcinoma


subject: UNII:2285XW22DR

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UNII:2285XW22DR

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:2285XW22DR

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:50853

subject_name: quantum dot

object_name: benign prostatic hyperplasia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: malignant testicular germ cell tumor


subject: UNII:28X28X9OKV

object_name: neoplasm of testis


subject: UNII:28X28X9OKV

object_name: testicular cancer


subject: UNII:28X28X9OKV

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:28X28X9OKV

object_name: primary cutaneous T-cell lymphoma


subject: UNII:28X28X9OKV

object_name: trabecular adenocarcinoma


subject: UNII:28X28X9OKV

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: renal carcinoma


subject: DRUGBANK:DB17293

object_name: kidney cancer


subject: DRUGBANK:DB17293

object_name: prostate carcinoma


subject: DRUGBANK:DB17293

object_name: prostate cancer


subject: DRUGBANK:DB17293

object_name: bladder tumor


subject: DRUGBANK:DB17293

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB17293

object_name: urinary bladder cancer


subject: DRUGBANK:DB17293

object_name: childhood bladder carcinoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: malignant soft tissue neoplasm


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: sarcoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073

object_name: malignant testicular germ cell tumor


subject: UMLS:C1948073

object_name: neoplasm of testis


subject: UMLS:C1948073

object_name: testicular cancer


subject: UMLS:C1948073

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C1948073

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C1948073

object_name: trabecular adenocarcinoma


subject: UMLS:C1948073

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:23724878

object_name: Bacteremia, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: colorectal carcinoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: immunodeficiency disease


subject: CHEBI:28793

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: atopic eczema


subject: CHEBI:27732

object_name: ulcerative colitis


subject: CHEBI:27732

object_name: inflammatory bowel disease 1


subject: CHEBI:27732

object_name: Crohn disease


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: UMLS:C2606889

subject_name: AEGR 733


subject: PUBCHEM.COMPOUND:86272868

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:86272868

object_name: interstitial lung disease 2


subject: PUBCHEM.COMPOUND:86272865


subject: PUBCHEM.COMPOUND:86272865


subject: CHEBI:58097

object_name: Lumbar Puncture Headache


subject: CHEBI:58097

object_name: cerebrospinal fluid leak


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:3638

subject_name: Chloroquine

object_name: osteoarthritis, knee


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: neurofibromatosis 1


subject: CHEBI:17549

object_name: neurofibromatosis type 1


subject: CHEBI:18295

subject_name: Histamine

object_name: Surgical procedure finding


subject: CHEBI:18295

object_name: Embolism, Tumor


subject: CHEBI:18295

object_name: Neoplasm Metastasis


subject: CHEBI:18295

object_name: Metastasis


subject: CHEBI:18295

object_name: Metastatic Lesion


subject: CHEBI:18295

object_name: Immunosuppression


subject: CHEBI:18295

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:18295

object_name: pancreatic neoplasm


subject: CHEBI:18295

object_name: exocrine pancreatic carcinoma


subject: CHEBI:18295

object_name: malignant pancreatic neoplasm


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:59112


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:63613

subject_name: Nevirapine

object_name: kidney failure


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Solid Neoplasm


subject: UNII:T6Q3060U91

subject_name: motesanib diphosphate

object_name: lung cancer


subject: UNII:T6Q3060U91

object_name: lung neoplasm


subject: UNII:T6Q3060U91

object_name: lung carcinoma


subject: UNII:T6Q3060U91

object_name: non-small cell lung carcinoma


subject: CHEBI:51098

subject_name: Motesanib


subject: UNII:Y68179SY2L

object_name: Adult Meningioma


subject: UNII:Y68179SY2L

object_name: benign meningioma


subject: UNII:Y68179SY2L

object_name: familial meningioma


subject: UNII:Y68179SY2L

object_name: pediatric meningioma


subject: UNII:Y68179SY2L

object_name: meningioma


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: chronic kidney disease


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: CHEBI:8378


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: functional gastric disease


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:D07V79Q44T

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: Uses oral contraception (finding)


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adult Burkitt Leukemia


subject: CHEBI:4026

object_name: Childhood Burkitt Leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:596

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: CD20 Positive


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879

object_name: Burkitt lymphoma


subject: CHEBI:41879

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:41879

object_name: Adult Burkitt Lymphoma


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: acute lymphoblastic leukemia


subject: CHEBI:28887

object_name: lymphoblastic lymphoma


subject: CHEBI:28887

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:28887

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:6015

subject_name: Isoflurane

object_name: acute respiratory distress syndrome


subject: CHEBI:6015

object_name: adult acute respiratory distress syndrome


subject: CHEBI:6015

object_name: Mechanical ventilation complication


subject: CHEBI:6015

object_name: Sedation complication


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: nasopharyngeal carcinoma


subject: CHEBI:5801

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: endometrium neoplasm


subject: CHEBI:79699

object_name: ovarian disease


subject: CHEBI:79699

object_name: female reproductive system disorder


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1

object_name: denture stomatitis


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:5801

object_name: pneumonia


subject: CHEBI:5801

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin


subject: PUBCHEM.COMPOUND:6427057


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:31781


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:145994

subject_name: Remdesivir


subject: CHEBI:145994


subject: CHEBI:31401

subject_name: Cilostazol

object_name: endogenous depression


subject: CHEBI:31401

object_name: major depressive disorder


subject: UMLS:C4331266

subject_name: SSTR2-targeting Protein/DM1 Conjugate PEN-221

object_name: neuroendocrine carcinoma


subject: UMLS:C4331266

object_name: neuroendocrine neoplasm


subject: UMLS:C4331266

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:155587867

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:155587867

object_name: Childhood Gastrointestinal Stromal Tumor


subject: PUBCHEM.COMPOUND:155587867

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:155587867

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:155587867

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:155587867

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:155587867

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:155587867

object_name: Neoplasm Metastasis


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UNII:Y6UHU32G5Z


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C3714501

object_name: COPD, severe early onset


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C0967936

subject_name: IH636 grape seed proanthocyanidin extract

object_name: Childhood Breast Carcinoma


subject: UMLS:C0967936

object_name: breast carcinoma


subject: UMLS:C0967936

object_name: breast cancer


subject: UMLS:C0967936

object_name: Radiation Fibrosis


subject: UMLS:C0967936

object_name: radiation pneumonitis


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Non-small cell carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UniProtKB:P13828

subject_name: MSP1_PLAYO Merozoite surface protein 1 (sprot)

object_name: Plasmodium falciparum malaria


subject: UMLS:C0169904

subject_name: Merozoite Surface Protein 1


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Bladder transitional cell carcinoma stage II


subject: PUBCHEM.COMPOUND:2767

object_name: infiltrating bladder urothelial carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Bladder transitional cell carcinoma stage III


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:156963654

object_name: cervical carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: multiple sclerosis


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:94805

subject_name: Ataluren

object_name: aniridia


subject: CHEBI:94805

object_name: aniridia 1


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: schizophrenia


subject: CHEBI:473990

subject_name: Entecavir

object_name: non-small cell lung carcinoma


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Hemodynamic instability


subject: CHEBI:140621

object_name: Suppression of adrenal gland


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:9316


subject: GTOPDB:12989

subject_name: toripalimab

object_name: exocrine pancreatic carcinoma


subject: UNII:8JXN261VVA


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: hypertension


subject: UNII:B72HH48FLU

object_name: Hypertension, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: interstitial cystitis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:139266768

subject_name: Injectafer

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:139266768

object_name: Iron deficiency


subject: PUBCHEM.COMPOUND:139266768

object_name: iron deficiency anemia


subject: UNII:6897GXD6OE


subject: UMLS:C0254503


subject: UMLS:C2699558

subject_name: Priligy

object_name: physiological sexual disorder


subject: UNII:U4OHT63MRI

subject_name: DAPOXETINE HYDROCHLORIDE


subject: UMLS:C0970823

subject_name: Dapoxetine hydrochloride


subject: UMLS:C3641718

subject_name: proellex

object_name: amenorrhea


subject: UMLS:C3641718

object_name: Amenorrhea, CTCAE


subject: CHEBI:92511

subject_name: Ketotifen

object_name: contracture


subject: CHEBI:94461

subject_name: Celiprolol

object_name: Postoperative cardiac complication


subject: CHEBI:169833

subject_name: Deacetyldiltiazem


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: UNII:82M942WZ4A

object_name: uveitis


subject: UNII:82M942WZ4A

object_name: Uveitis, CTCAE


subject: UNII:82M942WZ4A

object_name: cystoid macular edema


subject: UMLS:C1143399


subject: UMLS:C1143399


subject: UMLS:C1143399


subject: GTOPDB:13450

subject_name: briquilimab

object_name: chronic inducible urticaria


subject: UNII:QWX84D0DRC

subject_name: BRIQUILIMAB


subject: UMLS:C5418059

subject_name: AMG 191


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: non-Hodgkin lymphoma


subject: UMLS:C3854073

subject_name: Capsaicin 8% patch, per square centimeter

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Pancreatic carcinoma stage I


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901

object_name: Stage I Pancreatic Cancer AJCC v8


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: CHEBI:7496

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: Pancreatic carcinoma stage II


subject: CHEBI:7496

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: stage IB pancreatic cancer


subject: CHEBI:7496

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: stage IIB pancreatic cancer


subject: CHEBI:7496

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: stage IIA pancreatic cancer


subject: CHEBI:7496

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:7496

object_name: Pancreatic carcinoma stage III


subject: CHEBI:7496

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:7496

object_name: Pancreas carcinoma resectable


subject: CHEBI:7496

object_name: pancreatic adenocarcinoma


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Pancreatic carcinoma stage I


subject: UNII:HX101E7L6S

object_name: Stage I Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Pancreatic carcinoma stage II


subject: UNII:HX101E7L6S

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: stage IB pancreatic cancer


subject: UNII:HX101E7L6S

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: stage IIB pancreatic cancer


subject: UNII:HX101E7L6S

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: stage IIA pancreatic cancer


subject: UNII:HX101E7L6S

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:HX101E7L6S

object_name: Pancreatic carcinoma stage III


subject: UNII:HX101E7L6S

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Pancreas carcinoma resectable


subject: UNII:HX101E7L6S

object_name: pancreatic adenocarcinoma


subject: UMLS:C0664206

subject_name: Ovarex

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: Pancreatic carcinoma stage I


subject: UMLS:C0664206

object_name: Stage I Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: Pancreatic carcinoma stage II


subject: UMLS:C0664206

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: stage IB pancreatic cancer


subject: UMLS:C0664206

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: stage IIB pancreatic cancer


subject: UMLS:C0664206

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: stage IIA pancreatic cancer


subject: UMLS:C0664206

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C0664206

object_name: Pancreatic carcinoma stage III


subject: UMLS:C0664206

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0664206

object_name: Pancreas carcinoma resectable


subject: UMLS:C0664206

object_name: pancreatic adenocarcinoma


subject: UMLS:C2349988

subject_name: Myobacterium w (attenuated)


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Post-surgical hypoparathyroidism


subject: UMLS:C5446894

subject_name: Proteasome Inhibitor TQB3602

object_name: plasma cell myeloma


subject: UMLS:C0106006

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C0106006

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C0062248

subject_name: Hemoglobin B


subject: UMLS:C0062248


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: pyoderma gangrenosum


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: Musculoskeletal Pain


subject: CHEBI:16581

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:16581

object_name: Fatigue


subject: CHEBI:16581

object_name: Mental deterioration


subject: CHEBI:16581

object_name: Cognitive impairment


subject: DRUGBANK:DB17553

object_name: acute myeloid leukemia


subject: DRUGBANK:DB17553

object_name: lymphoma, non-Hodgkin, familial


subject: DRUGBANK:DB17553

object_name: non-Hodgkin lymphoma


subject: DRUGBANK:DB17553

object_name: Adult Non-Hodgkin Lymphoma


subject: DRUGBANK:DB17553

object_name: Childhood Non-Hodgkin Lymphoma


subject: DRUGBANK:DB17553

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB17553

object_name: Myelodysplasia


subject: DRUGBANK:DB17553

object_name: Adult Myelodysplastic Syndrome


subject: DRUGBANK:DB17553

object_name: childhood myelodysplastic syndrome


subject: DRUGBANK:DB17553

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: abdominal aortic aneurysm


subject: CHEBI:73604

object_name: aortic aneurysm, familial abdominal, 1


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Turner syndrome


subject: CHEBI:50838

object_name: primary ovarian failure


subject: CHEBI:50838

object_name: premature menopause


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin


subject: PUBCHEM.COMPOUND:147740


subject: PUBCHEM.COMPOUND:147740


subject: UMLS:C0939533


subject: UMLS:C0939533


subject: UMLS:C0939533


subject: CHEBI:68557

subject_name: bradykinin receptor antagonist

object_name: myocardial ischemia


subject: UMLS:C3850094

subject_name: Bradykinin Receptor Antagonists


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant


subject: UMLS:C0082926

subject_name: HOE 140


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: infertility


subject: CHEBI:184381

subject_name: Bacitracin

object_name: chronic rhinosinusitis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: prostatitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: DRUGBANK:DB12595

subject_name: Nerinetide

object_name: stroke disorder


subject: DRUGBANK:DB12595

object_name: cerebrovascular disorder


subject: DRUGBANK:DB12595

object_name: Stroke (heart beat)


subject: DRUGBANK:DB12595

object_name: Stroke, CTCAE


subject: UMLS:C4519149


subject: UMLS:C4519149


subject: UMLS:C4519149


subject: UMLS:C4519149


subject: UMLS:C0033307

subject_name: Progestational Hormones, Synthetic

object_name: Hyperplasia of the endometrium


subject: CHEBI:59826

subject_name: progestin


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C3536710

subject_name: Progestin [EPC]


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: malignant pleural mesothelioma


subject: PUBCHEM.COMPOUND:4469988

subject_name: Sabarubicin

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Shock


subject: CHEBI:28787

object_name: cardiogenic shock


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: Nausea and vomiting


subject: UNII:C5529G5JPQ


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: lung cancer


subject: UMLS:C0358855

object_name: lung neoplasm


subject: UMLS:C0358855

object_name: lung carcinoma


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: kidney disorder


subject: UMLS:C2962221

subject_name: TAC


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Myocardial Reperfusion Injury


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C3640127

subject_name: Anti-DLL4 Monoclonal Antibody MEDI0639

object_name: Solid Neoplasm


subject: CHEBI:45783

subject_name: Imatinib

object_name: acute myeloid leukemia


subject: CHEBI:91418

subject_name: Foretinib

object_name: renal cell carcinoma


subject: UMLS:C2973988


subject: UMLS:C2346741

object_name: Childhood Solid Neoplasm


subject: UMLS:C2346741

object_name: Adult Solid Neoplasm


subject: UMLS:C2346741


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: endometritis


subject: PUBCHEM.COMPOUND:53477758

object_name: chorioamnionitis


subject: PUBCHEM.COMPOUND:53477758

object_name: Infectious disorder of the fetus


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: CHEBI:5441

subject_name: Glyburide

object_name: Angina pectoris


subject: CHEBI:27732

subject_name: Caffeine

object_name: Parkinson disease


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UMLS:C4305648

subject_name: ACA 125

object_name: ovarian cancer


subject: UMLS:C4305648

object_name: ovarian neoplasm


subject: UMLS:C4305648

object_name: ovarian carcinoma


subject: UMLS:C4305648

object_name: fallopian tube neoplasm


subject: UMLS:C4305648

object_name: peritoneal neoplasm


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UMLS:C4329329


subject: CHEBI:5383

subject_name: Glimepiride

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:P8DD8KX4O4

subject_name: TOFOGLIFLOZIN


subject: CHEBI:136041

subject_name: Tofogliflozin


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: fetal growth restriction


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:46662

subject_name: mineral

object_name: Hyperuricemia


subject: CHEBI:46662

object_name: Hyperuricemia, CTCAE